Search Results - "Guérette, Benoit" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

by Smolen, Josef S, Prof, Emery, Paul, Prof, Fleischmann, Roy, Prof, van Vollenhoven, Ronald F, Prof, Pavelka, Karel, Prof, Durez, Patrick, Prof, Guérette, Benoît, PhD, Kupper, Hartmut, MD, Redden, Laura, MD, Arora, Vipin, PhD, Kavanaugh, Arthur, Prof
Published in The Lancet (British edition) (25.01.2014)

Get full text

Journal Article

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis

by Kavanaugh, Arthur, Gladman, Dafna D, Edwards, Christopher J, Schett, Georg, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Paris, Maria, Mease, Philip J
Published in Arthritis research & therapy (10.05.2019)

Get full text

Journal Article

Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study

Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study

by Gladman, Dafna D, Sampalis, John S, Illouz, Olivier, Guérette, Benoît
Published in Journal of rheumatology (01.09.2010)

Get more information

Journal Article

Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study

Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study

by Keystone, Edward C, Haraoui, Boulos, Guérette, Benoît, Mozaffarian, Neelufar, Liu, Shufang, Kavanaugh, Arthur
Published in Journal of rheumatology (01.02.2014)

Get more information

Journal Article

Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis

Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis

by Keystone, Edward C, van der Heijde, Désirée, Kavanaugh, Arthur, Kupper, Hartmut, Liu, Shufang, Guérette, Benoît, Mozaffarian, Neelufar
Published in Journal of rheumatology (01.09.2013)

Get more information

Journal Article

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

by Kavanaugh, Arthur, van Vollenhoven, Ronald F, Fleischmann, Roy, Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Chen, Su, Guérette, Benoît, Kupper, Hartmut, Smolen, Josef S
Published in Annals of the rheumatic diseases (01.02.2018)

Get full text

Journal Article

Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis

Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis

by Landewé, Robert, Smolen, Josef S, Florentinus, Stefan, Chen, Su, Guérette, Benoît, van der Heijde, Désirée
Published in Arthritis research & therapy (21.05.2015)

Get full text

Journal Article

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate

by Smolen, Josef S, van der Heijde, Désirée M, Keystone, Edward C, van Vollenhoven, Ronald F, Goldring, Mary B, Guérette, Benoît, Cifaldi, Mary A, Chen, Naijun, Liu, Shufang, Landewé, Robert B M
Published in Annals of the rheumatic diseases (01.07.2013)

Get full text

Journal Article

Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study

Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study

by Haraoui, Boulos, Cividino, Alfred, Stewart, Jacqueline, Guérette, Benoît, Keystone, Edward C
Published in BMC musculoskeletal disorders (17.11.2011)

Get full text

Journal Article

Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation

Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation

by Guérette, B, Asselin, I, Skuk, D, Entman, M, Tremblay, J P
Published in Cell transplantation (01.03.1997)

Get full text

Journal Article

Resting Lymphocyte Kinase (Rlk/Txk) Targets Lymphoid Adaptor SLP-76 in the Cooperative Activation of Interleukin-2 Transcription in T-cells

Resting Lymphocyte Kinase (Rlk/Txk) Targets Lymphoid Adaptor SLP-76 in the Cooperative Activation of Interleukin-2 Transcription in T-cells

by Schneider, Helga, Guerette, Benoit, Guntermann, Christine, Rudd, Christopher E.
Published in The Journal of biological chemistry (11.02.2000)

Get full text

Journal Article

Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

by Kinoshita, I, Vilquin, J T, Guérette, B, Asselin, I, Roy, R, Tremblay, J P
Published in Muscle & nerve (01.12.1994)

Get more information

Journal Article

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study

by Kavanaugh, Arthur, Fleischmann, Roy M, Emery, Paul, Kupper, Hartmut, Redden, Laura, Guerette, Benoit, Santra, Sourav, Smolen, Josef S
Published in Annals of the rheumatic diseases (01.01.2013)

Get full text

Journal Article

Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results

Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results

by Ogdie, Alexis, Liu, Mei, Glynn, Meghan, Emeanuru, Kelechi, Harrold, Leslie R, Richter, Sven, Guerette, Benoit, Mease, Philip J
Published in Journal of rheumatology (01.05.2021)

Get more information

Journal Article

Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients

Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients

by Wells, Alvin F, Edwards, Christopher J, Kivitz, Alan J, Bird, Paul, Guerette, Benoit, Delev, Nikolay, Paris, Maria, Teng, Lichen, Aelion, Jacob A
Published in Rheumatology (Oxford, England) (02.03.2022)

Get full text

Journal Article

13065 More moderate levels of disease severity at baseline related to achievement of treatment targets with apremilast: Results from a pooled analysis

13065 More moderate levels of disease severity at baseline related to achievement of treatment targets with apremilast: Results from a pooled analysis

by Lebwohl, Mark, Mrowietz, Ulrich, Menter, M. Alan, Griffiths, Christopher E.M., Bagel, Jerry, Gómez, Natalie Núnez, Shi, Rui, Shi, Rebecca, Guerette, Benoit, Levi, Eugenia, Reich, Kristian
Published in Journal of the American Academy of Dermatology (01.12.2020)

Get full text

Journal Article

Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection

Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection

by Huard, J, Roy, R, Guérette, B, Verreault, S, Tremblay, G, Tremblay, J P
Published in Muscle & nerve (01.02.1994)

Get more information

Journal Article

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

by Mease, Philip J., Gladman, Dafna D., Ogdie, Alexis, Coates, Laura C., Behrens, Frank, Kavanaugh, Arthur, McInnes, Iain, Queiro, Rubén, Guerette, Benoit, Brunori, Michele, Teng, Lichen, Smolen, Josef S.
Published in Arthritis care & research (2010) (01.06.2020)

Get full text

Journal Article

RCAS1 is associated with ductal breast cancer progression

RCAS1 is associated with ductal breast cancer progression

by Rousseau, Joel, Têtu, Bernard, Caron, Danielle, Malenfant, Patrick, Cattaruzzi, Paola, Audette, Marie, Doillon, Charles, Tremblay, Jacques P, Guérette, Benoit
Published in Biochemical and biophysical research communications (24.05.2002)

Get full text

Journal Article

Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials

Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials

by Mease, Philip J., Gladman, Dafna D., Kavanaugh, Arthur, McGonagle, Dennis, Nash, Peter, Guerette, Benoit, Nakasato, Priscila, Brunori, Michele, Teng, Lichen, McInnes, Iain B.
Published in Rheumatology and therapy. (01.12.2021)

Get full text

Journal Article